What is it about?
Despite important advances in therapy in the last decades, the quality of life (QOL) of patients with migraine remains severely deteriorated. In addition to significantly reducing the attack rate significantly, an effective preventive therapy should result in a significant improvement in the QOL of migraine patients. This objective is not often evaluated or achieved. Since mental domains are particularly deteriorated, we explored the effect of a combination therapy (antidepressant plus beta blocker) on the quality of life of migraine patients, but did not obtain positive results.
Featured Image
Why is it important?
Evaluating new preventive measures to improved the much deteriorated life of migraine patients is paramount. This work represents a new avenue by combining different approaches to migraine prevention (i.e., adding an atidepressant to conventional preventive therapy).
Perspectives
New avenues should be explored to improve migraine prevention and to ameliorate the quality of life of migraneurs.
Juan Carlos GARCIA MONCO
Hospital universitario de Basurto
Read the Original
This page is a summary of: Preventive therapy with citalopram added to a beta blocker does not result in quality-of-life improvement in patients with episodic migraine, Cephalalgia Reports, January 2018, SAGE Publications,
DOI: 10.1177/2515816318813545.
You can read the full text:
Contributors
The following have contributed to this page
